COVID Vaccine Labels To Warn of Rare Heart Risk
By I. Edwards HealthDay Reporter

FRIDAY, June 27, 2025 — The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.
The update expands earlier warnings about myocarditis, a type of heart inflammation, The Associated Press reported.
The condition is still very rare and usually mild, experts say.
The new label notes there were 8 cases of myocarditis for every 1 million people between 6 months and 64 years of age who received the 2023–2024 COVID-19 vaccine.
It also highlights that the highest risk group is males between ages 12 and 24. Previously, the label focused mostly on 12- to 17-year-olds.
The condition was first linked to COVID-19 vaccines in 2021. Doctors were already advised to watch for it, but the FDA asked Pfizer and Moderna in April to provide more detail and expand the age range included in the warning, The AP said.
Myocarditis is swelling in the heart muscle. It can cause chest pain, fatigue, or shortness of breath, according to the Mayo Clinic. In most cases, it gets better quickly with rest or medication.
Health experts stress that the condition is less severe than myocarditis caused by COVID-19 itself.
Some public health leaders worry the new warning is the wrong approach.
“They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,” Robert Morris, a public health expert at the University of Washington, told The AP.
“We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk,” he said.
The label update comes as a new U.S. Centers for Disease Control and Prevention (CDC) advisory panel, appointed by U.S. Health Secretary Robert F. Kennedy Jr., met to discuss vaccine guidance.
Kennedy recently removed all 17 previous members of the committee, replacing them with new members — some of whom have shared anti-vaccine views.
FDA Commissioner Dr. Marty Makary, a Kennedy appointee, has also restricted COVID-19 shots to seniors and high-risk individuals.
He and others have questioned the need for annual shots or seasonal tweaks to the vaccine, The Post reported.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-28 06:00
Read more

- FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
- Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
- Genetic Tests For Autism, Intellectual Disability Not Being Done On Medicaid Kids
- RFK Jr.-Appointed Vaccine Panel Removes Flu Shot Ingredient
- BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
- Many Kids Unnecessarily Hospitalized Following Allergic Reactions
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions